Indian pharmaceutical stocks faced a decline as a result of Donald Trump’s recent warning regarding tariffs on pharmaceutical imports. The Nifty Pharma index dropped by 1.7%, leading to notable decreases in leading companies such as Gland Pharma and Sun Pharma. Trump’s announcement emphasized the aim to encourage pharmaceutical firms to relocate their manufacturing operations to the United States by implementing tariffs. This move is expected to have a direct impact on India’s extensive generic drug exports to the US.